| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/10/2013 | CN102010425B 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/09/2013 | US8415302 Surgical applications for BMP binding protein |
| 04/09/2013 | CA2656356C Antiviral phosphinate compounds |
| 04/09/2013 | CA2583670C Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions |
| 04/09/2013 | CA2536436C 2-amido-4-aryloxy-1-carbonyl pyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/04/2013 | WO2013049697A1 Aromatic-cationic peptides and methods for using same |
| 04/04/2013 | WO2013048226A1 Immunomodulator metallopeptides (immps) and compositions containing same |
| 04/04/2013 | WO2013045854A1 Fluorogenic peptidase substrate |
| 04/04/2013 | WO2013044714A1 New method for preparing d-isoglutamyl-d-tryptophan |
| 04/04/2013 | US20130085259 Method and carrier complexes for delivering molecules to cells |
| 04/04/2013 | US20130085108 Peptides for promoting angiogenesis and an use thereof |
| 04/04/2013 | CA2850520A1 Aromatic-cationic peptides and methods for using same |
| 04/03/2013 | EP2574336A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/03/2013 | CN103025753A Crystalline ezatiostat hydrochloride ansolvate |
| 04/03/2013 | CN103012554A Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof |
| 04/03/2013 | CN103012553A Cortisone-RGD polypeptide conjugate, and preparation method and application thereof |
| 04/03/2013 | CN103012552A Bioactive polypeptide QEPV, and preparation and application thereof |
| 04/03/2013 | CN103012551A Synthetic method of high-purity bortezomib and intermediate thereof |
| 04/03/2013 | CN103012550A Preparation method of N (2)-L-alanyl-L-glutamine |
| 04/03/2013 | CN101421417B PCR hot start by magnesium sequestration |
| 04/03/2013 | CN101268093B Age抑制剂 Age Inhibitor |
| 04/02/2013 | US8409858 Modular functional peptides for the intracellular delivery of nanoparticles |
| 04/02/2013 | US8409817 Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| 04/02/2013 | CA2555792C Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 04/02/2013 | CA2546498C Peptide increasing fusiogenic capacity of a gamete |
| 04/02/2013 | CA2538075C Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 04/02/2013 | CA2494105C Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 03/28/2013 | US20130075703 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 03/27/2013 | EP2573083A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 03/27/2013 | EP2571576A2 N-(aminoacyl)-amino compound |
| 03/27/2013 | EP2571527A1 Cationic lipids |
| 03/27/2013 | CN102993271A Preparation method of glycyl-L-glutamine |
| 03/27/2013 | CN102993270A Preparation process of glycyl-L-tyrosine |
| 03/27/2013 | CN102993269A Cyclo-tetrapeptide compounds, preparation method thereof and application of cyclo-tetrapeptide compounds in preparation of anti-fouling agent |
| 03/27/2013 | CN102206247B Novel peptides as NS3/NS4a serine protease inhibitors of hepatitis C virus |
| 03/27/2013 | CN102030818B Peptide inhibiting angiontensin converting enzyme |
| 03/27/2013 | CN101565451B N-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester |
| 03/27/2013 | CN101160317B Process for preparing macrocyclic compounds |
| 03/26/2013 | US8404803 Cancer-associated antigen analogue peptides and uses thereof |
| 03/26/2013 | US8404646 Methods for preventing or treating mitochondrial permeability transition |
| 03/26/2013 | US8404244 Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 03/26/2013 | CA2395197C Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 03/21/2013 | WO2012173846A3 Peptidomimetic macrocycles |
| 03/21/2013 | US20130072438 Opioid peptide esters and methods of use |
| 03/21/2013 | US20130072431 Cardiovascular therapeutics |
| 03/21/2013 | US20130072422 Compounds for immunoproteasome inhibition |
| 03/21/2013 | US20130071863 Sulfur-Containing Amino Acid Derivative |
| 03/21/2013 | US20130071352 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 03/20/2013 | CN102985439A IAP BIR domain binding compounds |
| 03/20/2013 | CN102977186A Glycine-L-cysteine-homotaurine tripeptide and application thereof |
| 03/20/2013 | CN102977185A Preparation method of N(2)-L-alanyl-L-glutamine |
| 03/20/2013 | CN102492020B Pidotimod compound and new preparation method thereof |
| 03/20/2013 | CN102304169B Antihypertensive polypeptide and use thereof |
| 03/20/2013 | CN102276690B Blood pressure lowering functional polypeptide and application thereof |
| 03/20/2013 | CN102093250B Refining method of alanyl-glutamine compound |
| 03/20/2013 | CN101146819B Peptides that increase collagen or hyaluronic acid production |
| 03/20/2013 | CA2783359A1 Opioid peptide esters and methods of use |
| 03/19/2013 | US8399656 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 03/19/2013 | US8399612 Asymmetric synthesis of peptides |
| 03/19/2013 | US8399610 HPV vaccine comprising peptides from host cell proteins |
| 03/19/2013 | US8399233 Histone deacetylases, and uses related thereto |
| 03/19/2013 | US8399211 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
| 03/14/2013 | WO2013036889A1 Retrograde transport peptide and use of same for delivery to central nervous system |
| 03/14/2013 | WO2013034805A1 Neuroprotective cell-penetrating peptides |
| 03/14/2013 | US20130065827 Crystalline Peptide Epoxyketone Immunoproteasome Inhibitor |
| 03/14/2013 | US20130065308 Cationic lipids |
| 03/14/2013 | US20130065248 Reagents and methods for sirtuin capture |
| 03/13/2013 | EP2566880A1 Aromatic-cationic peptides and uses of same |
| 03/13/2013 | CN102964425A Conjugates of Docetaxel and simplified MDP analogue and anti-tumor effect |
| 03/13/2013 | CN102964424A Industrialized glycyl-L-glutamine synthetizing method suitable |
| 03/13/2013 | CN102060723B Preparation method of cationic liposome nanoparticles of amino acid |
| 03/13/2013 | CN101747410B Aminoacyl tyrosyl tryptophan tripeptide with easing pain activity and preparation method and application thereof |
| 03/13/2013 | CN101633636B Peptidomimetic protease inhibitors |
| 03/13/2013 | CN101228169B Macrocyclic inhibitors of hepatitis c virus |
| 03/12/2013 | US8394922 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 03/12/2013 | US8394769 Anti-hypertensive agent |
| 03/12/2013 | US8394758 Tumor-targeting peptides and uses thereof |
| 03/12/2013 | CA2727803C Metal abstraction peptide (map) tag and associated methods |
| 03/12/2013 | CA2562843C Process for the preparation of perindopril |
| 03/07/2013 | WO2013032411A1 Silk-based bioactive oligopeptide compositions and manufacturing process therefor |
| 03/07/2013 | US20130060006 Natural Flavour Enhancers and Methods for Making Same |
| 03/07/2013 | US20130059799 Aromatic-cationic peptides and uses of same |
| 03/07/2013 | CA2846852A1 Fap-activated proteasome inhibitors for treating solid tumors |
| 03/06/2013 | EP2564834A2 Compounds for Proteasome Enzyme Inhibition |
| 03/06/2013 | CN102952172A Pidotimod preparation method |
| 03/05/2013 | US8389791 Treatment devices and methods with extending elements |
| 03/05/2013 | US8389481 Glutamate-enhanced cell-penetrating peptides and methods of using same |
| 03/05/2013 | US8389240 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
| 03/05/2013 | CA2579119C Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/28/2013 | WO2013028664A1 Psma imaging agents |
| 02/28/2013 | WO2013026942A1 Tubulin binding agents |
| 02/28/2013 | WO2012158960A3 Melanocortin 1 receptor ligands and methods of use |
| 02/28/2013 | US20130053543 Peptide clearing agents |
| 02/28/2013 | US20130053325 Secondary Structure Stabilized NMDA Receptor Modulators and Uses Thereof |
| 02/28/2013 | CA2844386A1 Crystal forms of a hcv protease inhibitor |
| 02/27/2013 | EP2562180A1 Non-crystalline oxidized glutathione and production method therefor |
| 02/27/2013 | EP2562179A1 Crystalline oxidized glutathione and production method therefor |
| 02/27/2013 | EP2561065A2 Cell culture medium comprising small peptides |
| 02/27/2013 | CN102942615A Method for extracting glutathione from escherichia coli suspension liquid |